These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19143880)

  • 1. Hyperammonaemic encephalopathy associated with rituximab-containing chemotherapy.
    Nott L; Price TJ; Pittman K; Patterson K; Young R; Fletcher J
    Intern Med J; 2008 Oct; 38(10):800-3. PubMed ID: 19143880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A confused child. Diagnosis: urinary tract infection, dilated urinary system and associated hyperammonaemic encephalopathy.
    Fitzpatrick E; Mayne P; Gill D
    Pediatr Nephrol; 2007 Mar; 22(3):355-7. PubMed ID: 17039331
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metabolic encephalopathy can be a potentially life-threatening complication from valproic acid].
    Meinardi MC; van den Berg GB; Groenhuijzen A; Driessen JT; Maas HA; Wolfhagen FH
    Ned Tijdschr Geneeskd; 2008 Feb; 152(5):278-82. PubMed ID: 18333544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperammonaemic encephalopathy due to valproic acid in the neonatal period].
    Jiménez-Parrilla F; Pérez-Sánchez A; Núñez-Solís JM; Madruga-Garrido M; Losada-Martínez A
    Rev Neurol; 2009 Jun 1-15; 48(11):613-4. PubMed ID: 19472163
    [No Abstract]   [Full Text] [Related]  

  • 5. Fulminant progression of hyperammonaemic encephalopathy after treatment with valproate in a patient with ureterosigmoidostomy.
    Schwarz S; Georgiadis D; Schwab S; Gehlen F; Mayatepek E; Zoubaa S
    J Neurol Neurosurg Psychiatry; 2002 Jul; 73(1):90-1. PubMed ID: 12082063
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperammonaemic encephalopathy and severe metabolic acidosis in a patient with chronic renal insufficiency years after ureterosigmoidostomy.
    Hampel DJ; Stoll J; Nibbe L; Gollasch M
    Nephrol Dial Transplant; 2007 Sep; 22(9):2713-9. PubMed ID: 17556426
    [No Abstract]   [Full Text] [Related]  

  • 7. Extensive cortical magnetic resonance signal change in proximal urea cycle disorder.
    Bindu PS; Sinha S; Taly AB; Chandrasekhar HS; Christopher R; Arunodaya GR; Shetty T
    J Child Neurol; 2007 Feb; 22(2):238-9. PubMed ID: 17621492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncirrhotic hyperammonaemic encephalopathy.
    Laish I; Ben Ari Z
    Liver Int; 2011 Oct; 31(9):1259-70. PubMed ID: 21745294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cranial MRI in acute hyperammonemic encephalopathy.
    Bindu PS; Sinha S; Taly AB; Christopher R; Kovoor JM
    Pediatr Neurol; 2009 Aug; 41(2):139-42. PubMed ID: 19589465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hyperammonaemic encephalopathy due to valproic acid].
    Durán-Ferreras E; Jiménez-Vilches PL; Galá-Barranco JM; Fernández-Bolaños Porras R
    Rev Neurol; 2008 May 1-15; 46(9):537-9. PubMed ID: 18446695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A radiologic "alcohol breathalyzer" test.
    Wong SH; Smith T; White RP
    Neurology; 2009 Jan; 72(2):198. PubMed ID: 19139373
    [No Abstract]   [Full Text] [Related]  

  • 12. Valproate-induced hyperammonemic encephalopathy.
    Bhatia H; Raman PG
    J Assoc Physicians India; 2005 Feb; 53():158. PubMed ID: 15847043
    [No Abstract]   [Full Text] [Related]  

  • 13. Fatal course after administration of rituximab in a boy with relapsed all: a case report and review of literature.
    Seifert G; Reindl T; Lobitz S; Seeger K; Henze G
    Haematologica; 2006 Jun; 91(6 Suppl):ECR23. PubMed ID: 16785126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercises in clinical reasoning: a confusing interaction.
    Shah UA; Henderson MC; Abourjaily P; Thaler D; Rencic J
    J Gen Intern Med; 2015 Jun; 30(6):860-3. PubMed ID: 25623299
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical alertness to valproic acid-induced hyperammonemia--two case reports.
    Shan JC; Hsieh MH; Liu CC; Wen CC; Liu CM
    J Psychopharmacol; 2010 Jun; 24(6):943-5. PubMed ID: 19304858
    [No Abstract]   [Full Text] [Related]  

  • 16. Valproate-induced hyperammonaemic encephalopathy: review of 14 cases in the psychiatric setting.
    Dealberto MJ
    Int Clin Psychopharmacol; 2007 Nov; 22(6):330-7. PubMed ID: 17917551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired encephalopathy associated with carnitine deficiency after cefditoren pivoxil administration.
    Kim H; Chu K; Jung KH; Lee ST; Kim JM; Lee SK
    Neurol Sci; 2012 Dec; 33(6):1393-6. PubMed ID: 22258360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal involvement in valproate-induced acute hyperammonemic encephalopathy.
    Soares-Fernandes JP; Machado A; Ribeiro M; Ferreira C; Figueiredo J; Rocha JF
    Arch Neurol; 2006 Aug; 63(8):1202-3. PubMed ID: 16908754
    [No Abstract]   [Full Text] [Related]  

  • 19. Enterovirus infection of neuronal cells post-Rituximab.
    Kiani-Alikhan S; Skoulidis F; Barroso A; Nuovo G; Ushiro-Lumb I; Breuer J; Lister A; Mattes F
    Br J Haematol; 2009 Aug; 146(3):333-5. PubMed ID: 19466969
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperammonemia encephalopathy: an important cause of neurological deterioration following chemotherapy.
    Nott L; Price TJ; Pittman K; Patterson K; Fletcher J
    Leuk Lymphoma; 2007 Sep; 48(9):1702-11. PubMed ID: 17786705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.